Wolverine Trading, LLC Edwards Lifesciences Corp Call Options Transaction History

Wolverine Trading, LLC

$93.9 Billion
Q3 2024

Call Options

26 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$59.7 - $93.78 $13.1 Million - $20.5 Million	218,900 Added 269.25%	300,200 $19.8 Million
Q2 2024 Aug 14, 2024	SELL	$84.3 - $94.31 $961,020 - $1.08 Million	-11,400 Reduced 12.3%	81,300 $7.51 Million
Q1 2024 May 15, 2024	SELL	$72.54 - $95.56 $3.13 Million - $4.12 Million	-43,100 Reduced 31.74%	92,700 $8.86 Million
Q4 2023 Feb 14, 2024	BUY	$61.71 - $77.76 $1.59 Million - $2 Million	25,700 Added 23.34%	135,800 $10.4 Million
Q3 2023 Nov 15, 2023	BUY	$69.28 - $93.38 $1.81 Million - $2.44 Million	26,100 Added 31.07%	110,100 $7.63 Million
Q2 2023 Aug 23, 2023	BUY	$81.41 - $94.33 $3.38 Million - $3.91 Million	41,500 Added 97.65%	84,000 $7.92 Million
Q1 2023 May 15, 2023	SELL	$74.26 - $84.51 $913,398 - $1.04 Million	-12,300 Reduced 22.45%	42,500 $3.47 Million
Q4 2022 Feb 14, 2023	BUY	$68.3 - $87.44 $1.02 Million - $1.31 Million	15,000 Added 37.69%	54,800 $4.09 Million
Q3 2022 Nov 14, 2022	SELL	$82.37 - $107.29 $304,769 - $396,973	-3,700 Reduced 8.51%	39,800 $3.34 Million
Q2 2022 Aug 15, 2022	SELL	$86.5 - $128.27 $320,050 - $474,599	-3,700 Reduced 7.84%	43,500 $4.18 Million
Q1 2022 May 16, 2022	BUY	$101.96 - $128.34 $4.81 Million - $6.06 Million	47,200 New	47,200 $5.53 Million
Q4 2021 Feb 14, 2022	SELL	$106.37 - $130.68 $6.94 Million - $8.52 Million	-65,200 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$102.91 - $122.75 $6.71 Million - $8 Million	65,200 New	65,200 $7.4 Million
Q2 2021 Aug 06, 2021	SELL	$83.84 - $104.76 $2.29 Million - $2.86 Million	-27,300 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$78.68 - $90.67 $2.15 Million - $2.48 Million	27,300 New	27,300 $2.26 Million
Q4 2020 Feb 12, 2021	SELL	$71.69 - $91.23 $6.04 Million - $7.69 Million	-84,300 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$67.19 - $87.44 $5.66 Million - $7.37 Million	84,300 New	84,300 $6.6 Million
Q2 2020 Aug 13, 2020	SELL	$57.54 - $76.95 $1.64 Million - $2.19 Million	-28,500 Closed	0 $0
Q1 2020 May 11, 2020	SELL	$52.41 - $81.0 $1.47 Million - $2.27 Million	-28,000 Reduced 49.56%	28,500 $5.59 Million
Q4 2019 Feb 12, 2020	SELL	$71.7 - $82.09 $322,650 - $369,405	-4,500 Reduced 7.38%	56,500 $13.1 Million
Q3 2019 Nov 14, 2019	BUY	$61.55 - $75.43 $3.75 Million - $4.6 Million	61,000 New	61,000 $13.3 Million
Q2 2019 Aug 20, 2019	SELL	$55.74 - $64.41 $6.37 Million - $7.36 Million	-114,200 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$47.89 - $64.05 $2.75 Million - $3.68 Million	57,400 Added 101.06%	114,200 $21.9 Million
Q4 2018 Feb 14, 2019	BUY	$46.41 - $56.94 $413,048 - $506,766	8,900 Added 18.58%	56,800 $8.54 Million
Q3 2018 Nov 14, 2018	BUY	$45.7 - $58.03 $479,850 - $609,315	10,500 Added 28.07%	47,900 $8.34 Million
Q1 2018 May 15, 2018	BUY	$37.19 - $47.45 $1.39 Million - $1.77 Million	37,400 New	37,400 $5.22 Million

Others Institutions Holding EW

# of Institutions

1,350

Shares Held

457M

Call Options Held

9.76M

Put Options Held

3.92M

Vanguard Group Inc Valley Forge, PA

62.6M
Shares

$4.65 Billion
0.08% of portfolio
Black Rock Inc. New York, NY

51M
Shares

$3.78 Billion
0.11% of portfolio
Wellington Management Group LLP Boston, MA

31.5M
Shares

$2.34 Billion
0.37% of portfolio
State Street Corp Boston, MA

26.3M
Shares

$1.95 Billion
0.07% of portfolio
Geode Capital Management, LLC Boston, MA

13.5M
Shares

$1 Billion
0.07% of portfolio

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $45.9B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.

Account